ArticleDiabetes, obesity & metabolism2026
The Impact of Hypoglycaemia on Quality of Life in Adults With Type 1 Diabetes Using Contemporary Diabetes Technologies: A US National Survey.
Article in Diabetes, obesity & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Impact of Hypoglycaemia on Quality of Life in Adults With Type 1 Diabetes Using Contemporary Diabetes Technologies: A US National Survey.Diabetes, obesity & metabolism · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundUse of contemporary diabetes technologies, including continuous glucose monitoring (CGM) and hybrid closed-loop insulin pumps (HCLs), has expanded rapidly among people with Type 1 diabetes. However, limited research has characterised the impact of hypoglycaemia on quality of life in this population.
methodsWe analysed cross-sectional survey data from US adults aged ≥ 18 years who were using CGM or HCL and who were recruited through the T1D Exchange. Survey responses included participant characteristics, diabetes technology use, and hypoglycaemia-specific quality of life measured by the 12-item Hypoglycaemia Impact Profile (HIP-12), which assesses hypoglycaemia-related impact across 12 major life domains. HIP-12 composite and domain-specific scores were summarised and compared between CGM-only (without HCL) and HCL users.
resultsThe analytic sample included 796 participants (mean age 47 years; 53% female), of whom 23% used CGM only and 77% used HCL. Overall, 96% reported at least one life domain negatively affected by hypoglycaemia, and 31% reported negative impacts across 10 or more of the 12 assessed domains. The most frequently negatively affected domains were sleep, leisure activities, emotional well-being, spontaneity and physical activity/fitness. Compared with CGM-only users, HCL users reported greater hypoglycaemia-related negative impacts on leisure activities (p < 0.001), physical activity/fitness (p < 0.001), spontaneity (p = 0.011), sex life (p = 0.014) and work or studies (p = 0.021).
conclusionsHypoglycaemia continues to adversely affect multiple related quality-of-life domains despite using contemporary diabetes technologies. Routine clinical assessment of and clinical support for hypoglycaemia's impact remain important. Further research is needed to clarify the mechanisms underlying these impacts and to guide targeted interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.